Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Increases SIRT-1 activity as a result of enhanced NAD+ salvage, leading to beneficial epigenetic and metabolic reprogramming, including increased oxidative phosphorylation (OXPHOS) and muscle stem cell activation 1-3
The peptide was originally developed by Metabolic Pharmaceuticals in Australia
Lipotropic injections: An overview
Remember, peptide therapy is usually a part of a comprehensive weight management plan
Official Research Disclaimer The information provided in this guide is for informational and educational purposes only
Specifically amino acids 176191 from the C-terminal region
US$ 23.67
US$ 27.75
US$ 22.47
US$ 27.74
US$ 29.44
